Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Discovery of NVP-LEQ506, a second generation inhibitor of Smoothened

He, Feng and Dai, Miao and Zhang, Rui and Sun, Yingchuan and Miller-Moslin, Karen and McEwan, Michael and Lagu, Bharat and Wang, Kate and Kelleher Iii, Joseph and Dorsch, Marion and Buonamici, Silvia and Maniara, Wieslawa and Peukert, Stefan and Bourret, Aaron and Ramamurthy, Arun and Williams, Juliet and Green, John and Amaral, Adam and Vattay, Anthony and Wang, Anlai and Guo, Ribo and Yuan, Jing and Yusuff, Naeem (2013) Discovery of NVP-LEQ506, a second generation inhibitor of Smoothened. ChemMedChem, 8 (8). pp. 1261-1265. ISSN 1860-7179

Abstract

Inhibition of the Hedgehog (Hh) pathway targeting the Smoothened receptor has proven therapeutic benefit for the treatment of Hh-dependent cancers. Lead optimization provided a novel type of Smoothened inhibitor based on a pyridazine core resulting in the clinical compound NVP-LEQ506. This new agent combines high intrinsic potency and good pharmacokinetic properties resulting in excellent efficacy in preclinical rodent tumor models of medulloblastoma. Activity against a Smo mutant conferring resistance observed in a clinical trial with a competitor compound suggests additional therapeutic potential.

Item Type: Article
Related URLs:
Additional Information: Manuscript is accompanied by a cover page of the issue
Keywords: Hedgehog signalling, Smoothened, antitumor agent
Related URLs:
Date Deposited: 13 Oct 2015 13:15
Last Modified: 13 Oct 2015 13:15
URI: https://oak.novartis.com/id/eprint/4854

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.